Free shipping on all orders over $ 500


Cat. No. M1744
ARRY-162 Structure

MEK-162, ARRY-438162

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mg USD 67 In stock
50mg USD 170 In stock
100mg USD 260 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

ARRY-162 is a selective, potent inhibitor of MEK and cellular pERK with IC50 of 12 nM and 11 nM, respectively. ARRY-162 (MEK-162) shows ex vivo inhibition of cytokine production such as IL-1, TNF and IL-6 in clinical trials. MEK signaling pathway acts as a central axis in the proliferation of different tumors including melanoma, non-small cell lung, head/neck and pancreatic cancers. And MEK inhibition is an important therapeutic strategy in treating cancer either alone or in combination with other agents. ARRY-162 has the potential to treat a range of malignant diseases.

Product Citations
Customer Product Validations & Biological Datas
Source Cell Death and Disease (2014) 5, e1134. Figure 5. ARRY-162 were obtained from AbMole BioScience, HongKong, China,
Method Flow cytometric enumeration of propidium iodide staining
Cell Lines U266, OPM2, RPMI8226, OCIMY1
Concentrations 1µM
Incubation Time 72 hours
Results It was clear that LBH589 was found to be synergistic with MAPK and FAK inhibitors in all HMCL.
Cell Experiment
Cell lines A549 and H460 human lung cancer cell lines
Preparation method Cells were collected and seeded in 96-well plates at a density of 5×103 cells/well. Human lung cancer A549 cells or H460 cells were untreated or treated with indicated concentration of perifosine (0.3–10 μM), in the presence or absence of MEK-162 (1 μM); for 24 or 72 h, cell growth was tested by MTT assay.
Concentrations 1μM
Incubation time 24 or 72 h
Animal Experiment
Animal models A549 lung cancer xenograft
Formulation Formulated in 30% Captisol
Dosages 2.5 mg/kg, once daily
Administration lavage
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 441.23
Formula C17H15BrF2N4O3
CAS Number 606143-89-9
Purity >98%
Solubility DMSO 65 mg/mL
Storage at -20°C

Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo
Jianli Zhang,et,al. Tumor Biol. 2015;36:5699–5706.

Related MEK Products

trans-Zeatin is a plant cytokinin, which plays an important role in cell growth, differentiation, and division.


RO4987655 is an orally active and highly selective MEK inhibitor with an IC50 of 5.2 nM.


BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor with IC50 of 3 nM, 25 nM, 15 nM, 25 nM, and 4 nM for Xenopus laevis Aurora B, human Aurora A and Aurora C, as well as human MEK1 and MEK2, respectively.


LY2801653 is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase(Ki= 2 nM).


Refametinib (BAY 86-9766, RDEA119) is a potent, highly selective and ATP non-competitive inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.

Abmole Inhibitor Catalog 2017

Keywords: ARRY-162, MEK-162, ARRY-438162 supplier, MEK, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.